Skip to main content
Log in

The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML)

  • Letter to the editor
  • Published:
Journal of Hematopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on request.

References

  1. Grimwade D, Hills RK, Moorman AV et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354–365

    Article  CAS  PubMed  Google Scholar 

  2. Dohner H et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424–447

    Article  PubMed  PubMed Central  Google Scholar 

  3. Swerdlow SH et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, France

Download references

Funding

The author(s) received no financial support for the research, authorship and publication of this article.

Author information

Authors and Affiliations

Authors

Contributions

ST and KX wrote up the manuscript. ST, RB, EN, JO, RG, AW and KX critically revised the final version of the manuscript.

Corresponding author

Correspondence to Ke Xu.

Ethics declarations

Ethical approval

Not required for this audit.

Informed consent

Not applicable.

Consent for publication

For this audit, consent for publication is not required.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 426 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tayabali, S., Baker, R., Nacheva, E. et al. The use of leukaemia Q-fusion gene screening assay (Q30) in the diagnostic evaluation of acute myeloid leukaemia (AML). J Hematopathol 17, 37–39 (2024). https://doi.org/10.1007/s12308-023-00571-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12308-023-00571-6

Navigation